doi.org/10.1111/bph.13317, hdl.handle.net/1765/85204
British Journal of Pharmacology
Department of Medical Oncology

Huisman, S., de Bruijn, P., Ghobadi Moghadam-Helmantel, I., IJzermans, J., Wiemer, E., Mathijssen, R., & de Bruin, R. (2016). Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice. British Journal of Pharmacology, 173(5), 804–814. doi:10.1111/bph.13317